Although mice with targeted activation of Kras and loss of p53 (Kras-p53) in the liver spontaneously develop cholangiocarcinoma recapitulating the histological features of human disease, the composition of the tumor microenvironment (TME) remains largely unknown. The gene discussed is TP53; the disease is neoplasm.